RxDoctor Payments Data

Mark Pinto, MD

Orthopaedic Surgery · Chelsea, MINPI 1033228903

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $3,180,835 of the $3,196,366 with a category attached, or 99.5%. Arthrex accounts for 99.9% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $648,748, 2.2 times the $295,783 reported in 2019. Among orthopaedic surgery clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,196,366in general payments, 2019–2025

Across 165 payments — averaging $19,372 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$3.2M
  • Pinnacle, Inc$3K
  • Linvatec Corporation$541
  • Stryker$317
  • DJO, LLC$49
  • My01 Inc.$20

What the payments were for

  • Royalty or licence$3,180,835100%
  • Travel & lodging$8,2210%
  • Food & beverage$4,6160%
  • Education$2,6930%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex127$3,192,180
Pinnacle, Inc29$3,260
Linvatec Corporation5$541
Stryker2$317
DJO, LLC1$49
My01 Inc.1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,196,366 in reported general payments places this provider in the 95th percentile of 829 orthopaedic surgery providers in Michigan.

See all orthopaedic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$59,219
Medicare patients
211
Services billed
578

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam276$595
Methylprednisolone31$129

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Chelsea

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →